West Pharmaceutical Services (WST)
R&D Expense Growth
7.53%
Fiscal year · Period ending:
WST R&D Expense Growth
Latest reported7.53%period ending
Latest reported7.53%period ending
WST FY R&D Growth (YoY) (0.00% → 7.53%)
Latest values, visible window
High-resolution chart · PNG
WST r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 7.5253% | |
| 1.0234% | |
| 16.9231% | |
| 10.7955% | |
| 12.58% | |
| 20.5656% | |
| -3.4739% | |
| 3.0691% | |
| 6.25% | |
| 7.9179% | |
| -8.5791% | |
| -1.5831% | |
| 14.1566% | |
| 14.0893% | |
| 21.7573% | |
| 20.1005% | |
| 6.4171% | |
| 16.1491% | |
| 45.045% | |
| 40.5063% | |
| 25.3968% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |